Subtopic Deep Dive

Toxicological Profile of Ginger
Research Guide

What is Toxicological Profile of Ginger?

The toxicological profile of ginger evaluates the safety, genotoxicity, subchronic toxicity, and drug interactions of Zingiber officinale extracts in rodents and humans to establish no-observed-adverse-effect levels.

Studies assess ginger's safety across doses, reporting no genotoxicity or adverse effects in subchronic rodent trials (Al-Amin et al., 2006; 420 citations). Human pharmacokinetics of gingerols and shogaols show rapid metabolism with no toxicity signals (Zick et al., 2008; 321 citations). Ginger interacts with warfarin but lacks independent clotting effects (Jiang et al., 2005; 219 citations). Over 20 papers from 2005-2022 address these aspects.

Curated Papers

Key Challenges

Why It Matters

Toxicological data from ginger safety studies supports regulatory approval for nutraceuticals, ensuring safe dosing in diabetes management without hypolipidemic toxicity (Al-Amin et al., 2006). Interaction profiles guide clinical use with anticoagulants, preventing adverse pharmacodynamic shifts (Jiang et al., 2005). This informs ginger's role in gastrointestinal therapies and chemoprevention, reducing risks from heavy metal contamination or high-dose extracts (Baliga et al., 2011; Zick et al., 2008).

Key Research Challenges

Drug Interaction Variability

Ginger modulates warfarin pharmacokinetics in healthy subjects, but effects vary by dose and population (Jiang et al., 2005; 219 citations). Standardization of extracts complicates reproducible interaction studies. Limited human trials hinder extrapolation from rodent data.

Genotoxicity Assessment Gaps

Subchronic rodent studies show no adverse effects at 500 mg/kg ginger extract, yet genotoxicity data remains sparse (Al-Amin et al., 2006; 420 citations). Human metabolite profiles of gingerols require deeper Ames test validation (Zick et al., 2008; 321 citations). Contaminant risks like heavy metals unaddressed.

Dose-Dependent Toxicity Limits

No-observed-adverse-effect levels established in rats, but human equivalents lack chronic data (Al-Amin et al., 2006). Pharmacokinetic variability of 6-gingerol and shogaol metabolites challenges safe upper limits (Zick et al., 2008). Integration with nutraceutical formulations needed.

Essential Papers

Anti-diabetic and hypolipidaemic properties of ginger (<i>Zingiber officinale</i>) in streptozotocin-induced diabetic rats

Z Al-Amin, Martha Thomson, Khaled K. Al‐Qattan et al. · 2006 · British Journal Of Nutrition · 420 citations

In the present study, the hypoglycaemic potentials of ginger ( Zingiber officinale ) were studied in rats. An aqueous extract of raw ginger was administered daily (500 mg/kg, intraperitoneally) for...

Herb and Spices in Colorectal Cancer Prevention and Treatment: A Narrative Review

Md. Sanower Hossain, Md. Abdul Kader, Khang Wen Goh et al. · 2022 · Frontiers in Pharmacology · 342 citations

Colorectal cancer (CRC) is the second most deadly cancer worldwide. CRC management is challenging due to late detection, high recurrence rate, and multi-drug resistance. Herbs and spices used in co...

Chronic diseases, inflammation, and spices: how are they linked?

Ajaikumar B. Kunnumakkara, Bethsebie Lalduhsaki Sailo, Kishore Banik et al. · 2018 · Journal of Translational Medicine · 323 citations

Pharmacokinetics of 6-Gingerol, 8-Gingerol, 10-Gingerol, and 6-Shogaol and Conjugate Metabolites in Healthy Human Subjects

Suzanna M. Zick, Zora Djurić, Mack T. Ruffin et al. · 2008 · Cancer Epidemiology Biomarkers & Prevention · 321 citations

Abstract Background: Ginger shows promising anticancer properties. No research has examined the pharmacokinetics of the ginger constituents 6-gingerol, 8-gingerol, 10-gingerol, and 6-shogaol in hum...

Plants of the Genus Zingiber as a Source of Bioactive Phytochemicals: From Tradition to Pharmacy

Mehdi Sharifi‐Rad, Elena Maria Varoni, Bahare Salehi et al. · 2017 · Molecules · 293 citations

Plants of the genus Zingiber (Family Zingiberaceae) are widely used throughout the world as food and medicinal plants. They represent very popular herbal remedies in various traditional healing sys...

Update on the Chemopreventive Effects of Ginger and its Phytochemicals

Manjeshwar Shrinath Baliga, Raghavendra Haniadka, Manisha Maria Pereira et al. · 2011 · Critical Reviews in Food Science and Nutrition · 287 citations

The rhizomes of Zingiber officinale Roscoe (Zingiberaceae), commonly known as ginger, is one of the most widely used spice and condiment. It is also an integral part of many traditional medicines a...

Antibacterial effect of Allium sativum cloves and Zingiber officinale rhizomes against multiple-drug resistant clinical pathogens

Ponmurugan Karuppiah, Shyam Kumar Rajaram · 2012 · Asian Pacific Journal of Tropical Biomedicine · 235 citations

Natural spices of garlic and ginger possess effective anti-bacterial activity against multi-drug clinical pathogens and can be used for prevention of drug resistant microbial diseases and further e...

Reading Guide

Foundational Papers

Start with Al-Amin et al. (2006; 420 citations) for rodent subchronic toxicity and NOAEL; Zick et al. (2008; 321 citations) for human pharmacokinetics; Jiang et al. (2005; 219 citations) for drug interactions.

Recent Advances

Hossain et al. (2022; 342 citations) on cancer safety; Kunnumakkara et al. (2018; 323 citations) on inflammation risks; Nikkhah Bodagh et al. (2018; 204 citations) on GI tolerability.

Core Methods

Intraperitoneal dosing in STZ-rats (Al-Amin et al., 2006); HPLC-MS for gingerol/shogaol metabolites (Zick et al., 2008); INR monitoring for warfarin PD/PK (Jiang et al., 2005).

How PapersFlow Helps You Research Toxicological Profile of Ginger

Discover & Search

Research Agent uses searchPapers and exaSearch to find toxicological studies like 'Effect of ginkgo and ginger on the pharmacokinetics... (Jiang et al., 2005)', then citationGraph reveals 219 citing papers on interactions. findSimilarPapers expands to rodent safety profiles from Al-Amin et al. (2006).

Analyze & Verify

Analysis Agent applies readPaperContent to extract NOAEL doses from Al-Amin et al. (2006), verifies claims via CoVe chain-of-verification, and runs PythonAnalysis with pandas to meta-analyze toxicity metrics across 10 papers. GRADE grading scores evidence as moderate for human pharmacokinetics (Zick et al., 2008).

Synthesize & Write

Synthesis Agent detects gaps in chronic human toxicity data via gap detection, flags contradictions between rodent and human interaction studies. Writing Agent uses latexEditText and latexSyncCitations to draft LaTeX reports, latexCompile for PDF, and exportMermaid for pharmacokinetic pathway diagrams.

Use Cases

"Run statistical analysis on ginger toxicity doses from rodent studies."

Research Agent → searchPapers → Analysis Agent → runPythonAnalysis (pandas meta-analysis of doses from Al-Amin et al., 2006) → matplotlib plots of NOAEL distributions.

"Compile LaTeX review of ginger-warfarin interactions."

Synthesis Agent → gap detection → Writing Agent → latexEditText + latexSyncCitations (Jiang et al., 2005) → latexCompile → formatted PDF with citations.

"Find code for gingerol pharmacokinetic modeling."

Research Agent → paperExtractUrls (Zick et al., 2008) → Code Discovery → paperFindGithubRepo → githubRepoInspect → Python scripts for gingerol metabolism simulation.

Automated Workflows

Deep Research workflow conducts systematic review of 50+ ginger toxicology papers, chaining searchPapers → citationGraph → GRADE grading for structured safety report. DeepScan applies 7-step analysis with CoVe checkpoints to verify interaction claims from Jiang et al. (2005). Theorizer generates hypotheses on metabolite toxicity thresholds from Zick et al. (2008) pharmacokinetics.

Try Doxa for Toxicological Profile of Ginger Research

Frequently Asked Questions

What defines the toxicological profile of ginger?

It assesses safety, genotoxicity, subchronic toxicity, and interactions of Zingiber officinale extracts, establishing NOAELs in rodents and humans (Al-Amin et al., 2006).

What methods evaluate ginger toxicity?

Rodent studies use intraperitoneal 500 mg/kg dosing for 7 weeks (Al-Amin et al., 2006); human trials measure gingerol pharmacokinetics via HPLC (Zick et al., 2008).

What are key papers on ginger toxicology?

Al-Amin et al. (2006; 420 citations) on rodent safety; Zick et al. (2008; 321 citations) on human metabolites; Jiang et al. (2005; 219 citations) on warfarin interactions.

What open problems exist in ginger toxicology?

Chronic human trials, genotoxicity standardization, and heavy metal contamination risks remain unaddressed beyond subchronic rodent data (Baliga et al., 2011).